Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis

Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats

(2010) Yao-Chi Chuang et al.   BJU INTERNATIONAL

Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model

(2009) Narisato Hamada et al.   ATHEROSCLEROSIS

Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus

(2009) Naoki Inagaki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Gender-based reciprocal expression of transforming growth factor-β1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis

(2009) Pradeep Tyagi et al.   Journal of Inflammation-London

Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Liposomes

(2009) Yao-Chi Chuang et al.   JOURNAL OF UROLOGY

Differential effects of immunosuppressive drugs on COX-2 activity in vitro and in kidney transplant patients in vivo

(2009) B. Jespersen et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Transcriptional regulation of IL-2 in health and autoimmunity

(2008) José C. Crispín et al.   AUTOIMMUNITY REVIEWS

Safety and Tolerability of Adjuvant Topical Tacrolimus Treatment in Boys with Lichen Sclerosus: A Prospective Phase 2 Study

(2008) Anne K. Ebert et al.   EUROPEAN UROLOGY

Intravesical Botulinum Toxin A Administration Inhibits COX-2 and EP4 Expression and Suppresses Bladder Hyperactivity in Cyclophosphamide-Induced Cystitis in Rats

(2008) Yao-Chi Chuang et al.   EUROPEAN UROLOGY

Multiplex Analysis of Urinary Cytokine Levels in Rat Model of Cyclophosphamide-induced Cystitis

(2008) Marc C. Smaldone et al.   UROLOGY